Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

MRI in autosomal dominant polycystic kidney disease.

Zhang W, Blumenfeld JD, Prince MR.

J Magn Reson Imaging. 2019 Jan 13. doi: 10.1002/jmri.26627. [Epub ahead of print] Review.

PMID:
30637853
2.

Relationship of Seminal Megavesicles, Prostate Median Cysts, and Genotype in Autosomal Dominant Polycystic Kidney Disease.

Zhang W, Stephens CJ, Blumenfeld JD, Behzadi AH, Donahue S, Bobb WO, Newhouse JH, Rennert H, Zhao Y, Prince MR.

J Magn Reson Imaging. 2019 Mar;49(3):894-903. doi: 10.1002/jmri.26289. Epub 2018 Sep 19.

PMID:
30230107
3.

Bladder diverticuli following injection of onabotulinum toxin A in a patient with multiple sclerosis and autosomal dominant polycystic kidney disease.

Raza SI, Behzadi AH, Blumenfeld JD, Girardi SK, Prince MR.

Radiol Case Rep. 2018 Jun 1;13(5):1021-1024. doi: 10.1016/j.radcr.2018.04.006. eCollection 2018 Oct.

4.

Comparison of MRI segmentation techniques for measuring liver cyst volumes in autosomal dominant polycystic kidney disease.

Farooq Z, Behzadi AH, Blumenfeld JD, Zhao Y, Prince MR.

Clin Imaging. 2018 Jan - Feb;47:41-46. doi: 10.1016/j.clinimag.2017.07.004. Epub 2017 Jul 12.

PMID:
28846875
5.

Complex liver cysts in Autosomal Dominant Polycystic Kidney Disease.

Farooq Z, Behzadi AH, Blumenfeld JD, Zhao Y, Prince MR.

Clin Imaging. 2017 Nov - Dec;46:98-101. doi: 10.1016/j.clinimag.2017.07.014. Epub 2017 Jul 25.

PMID:
28768225
6.

Unsuccessfully Treated Hypertension: A Major Public Health Problem With a Potential Solution.

Furberg CD, Sealey JE, Blumenfeld JD.

Am J Hypertens. 2017 Sep 1;30(9):857-860. doi: 10.1093/ajh/hpx068.

PMID:
28482060
7.

Seminal Vesicles in Autosomal Dominant Polycystic Kidney Disease.

Kim JA, Blumenfeld JD, Prince MR.

In: Li X, editor. Polycystic Kidney Disease [Internet]. Brisbane (AU): Codon Publications; 2015 Nov. Chapter 18.

8.

Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.

Kim JA, Blumenfeld JD, Chhabra S, Dutruel SP, Thimmappa ND, Bobb WO, Donahue S, Rennert HE, Tan AY, Giambrone AE, Prince MR.

Radiology. 2016 Sep;280(3):762-70. doi: 10.1148/radiol.2016151650. Epub 2016 Apr 5.

9.

Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline.

Ben-Dov IZ, Tan YC, Morozov P, Wilson PD, Rennert H, Blumenfeld JD, Tuschl T.

PLoS One. 2014 Jan 29;9(1):e86856. doi: 10.1371/journal.pone.0086856. eCollection 2014.

10.

Cisterna chyli in autosomal dominant polycystic kidney disease.

Thimmappa ND, Blumenfeld JD, Cerilles MA, Dunning A, Donahue SL, Bobb WO, Zhang HL, Prince MR.

J Magn Reson Imaging. 2015 Jan;41(1):142-8. doi: 10.1002/jmri.24527. Epub 2014 Jan 27.

PMID:
24470398
11.

Tolvaptan inhibition of desmopressin effects on coagulation factors in a patient with decreased von Willebrand factor and polycystic kidney disease.

Blumenfeld JD, Tepler J, Mauer A, Coller B, Bichet DG, Smith B.

Blood. 2011 Jul 14;118(2):474-6. doi: 10.1182/blood-2011-04-347328. No abstract available.

12.

Kidney function and volume progression in unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis or hypoplasia: a case series.

Poster D, Kistler AD, Krauer F, Blumenfeld JD, Rennert H, Weishaupt D, W├╝thrich RP, Serra AL.

Am J Kidney Dis. 2009 Sep;54(3):450-8. doi: 10.1053/j.ajkd.2009.03.020. Epub 2009 Jun 10. Erratum in: Am J Kidney Dis. 2011 Jul;58(1):156.

PMID:
19515475
13.

Pretransplant genetic testing of live kidney donors at risk for autosomal dominant polycystic kidney disease.

Blumenfeld JD.

Transplantation. 2009 Jan 15;87(1):6-7. doi: 10.1097/TP.0b013e318191965d. No abstract available.

14.

Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease.

Tan YC, Blumenfeld JD, Anghel R, Donahue S, Belenkaya R, Balina M, Parker T, Levine D, Leonard DG, Rennert H.

Hum Mutat. 2009 Feb;30(2):264-73. doi: 10.1002/humu.20842.

PMID:
18837007
15.

Plasma renin activity for predicting antihypertensive drug efficacy.

Blumenfeld JD.

Am J Hypertens. 2008 Jan;21(1):5-6. No abstract available.

PMID:
18091734
16.

A free-ranging roundtable discussion on hypertension.

Standridge JB, Sealey JE, Laragh JH, Houston MC, Gavras H, Johnson RJ, Blumenfeld JD, Brown M, Egan BM, Meltzer JI, Shimosawa T, Fujita T.

J Hum Hypertens. 2005 Apr;19(4):259-66. No abstract available.

PMID:
15716983
17.

Plagiarism and scientific misconduct.

Catanzaro DF, Blumenfeld JD, Laragh JH.

Am J Hypertens. 2004 Nov;17(11 Pt 1):1077. No abstract available.

PMID:
15533738
18.

JNC-7 versus renin-based strategies for optimal antihypertensive drug treatment. Another look at the evidence.

Blumenfeld JD.

Am J Hypertens. 2004 Oct;17(10):1002-4. Review. No abstract available.

PMID:
15485767
19.

Renin system activation and delayed function of the renal transplant.

Blumenfeld JD, Catanzaro DF, Kinkhabwala M, Cheigh J, Hartono C, Serur D, Kapur S, Stubenbord WT, Haschemeyer R, Riggio R.

Am J Hypertens. 2001 Dec;14(12):1270-2. Review.

PMID:
11775137
20.

Management of hypertensive crises: the scientific basis for treatment decisions.

Blumenfeld JD, Laragh JH.

Am J Hypertens. 2001 Nov;14(11 Pt 1):1154-67. Review.

PMID:
11724216

Supplemental Content

Loading ...
Support Center